Press Releases | DEA.gov
Skip to main content
U.S. flag

An official website of the United States government

Here’s how you know

Dot gov

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Https

Secure .gov websites use HTTPS
A lock ( Lock A locked padlock ) or https:// means you’ve safely connected to the .gov website. Share sensitive information only on official, secure websites.

  • Who We Are
    • About
    • Mission
    • Leadership
    • History
    • Divisions
      • Domestic Divisions
      • Foreign Divisions
      • Operational Divisions
    • DEA Museum
    • Wall of Honor
    • Contact Us
      • Submit a Tip
      • Extortion Scam
      • Public Affairs
      • Social Media Directory
  • What We Do
    • Forensic Sciences
      • GUARDS
      • Forensic Sciences Policy
      • Forensic Science Organizations
      • Forensic Science Contact
    • Law Enforcement
      • DEA Office of Training
        • Office of Training Programs
      • El Paso Intelligence Center (EPIC)
      • Intelligence
      • Operations
        • Administrative Law Judges
        • DEA Asset Forfeiture
        • Domestic Cannabis Suppression / Eradication Program
        • HIDTA
        • OCDETF
    • Education and Prevention
      • Family Summit
      • Red Ribbon
      • Kiki and the History of Red Ribbon Week
      • Red Ribbon Toolkit - Resources For Your Community
      • DEA’s Family Summit
      • Operation Engage
      • Community Outreach
      • Just Think Twice
      • Campus Drug Prevention
      • Get Smart About Drugs
      • Operation Prevention
    • Drug Information
      • Drug Policy
      • Drug Scheduling
      • The Controlled Substances Act
    • News
      • Alerts
      • Press Releases
      • Most Wanted Fugitives
        • All Fugitives
      • Stories
      • Events
      • Speeches
      • Testimony
    • Campaigns
      • One Pill Can Kill
        • Senior Citizens
        • Partner Toolbox
        • Social Media Campaign
      • DEA National Prescription Drug Take Back Day
  • Careers
    • Special Agent
      • Special Agent FAQs
    • Diversion Investigator
      • Diversion Investigator Job Announcement
    • Intelligence Research Specialist
      • Intelligence Research Specialist Job Announcements
      • Intelligence Research Specialists FAQs
      • Schedule A Hiring Authority: Intelligence Research Specialist
    • Forensic Sciences Careers
    • Professional & Administrative Careers
    • Student & Entry Level Careers
    • Employment Eligibility
    • How to Apply
      • How To Claim Veterans' Preference
      • Priority Consideration
      • Benefits
      • Veterans and People With Disabilities
      • Operation Warfighter
  • Resources
    • Cartels
    • Illegal Online Pharmacies
    • OD Justice
    • Fentanyl Supply Chain
    • Pill Press Resources
    • Recovery Resources
    • Together for Families
    • Data and Statistics
      • Domestic Arrests
      • Staffing and Budget
    • FOIA
      • About FOIA
      • Contact DEA FOIA
      • Make a Request
      • What Happens After Making a Request
      • Requester Categories
      • Fees Charged
      • Fee Waiver
      • FOIA FAQ
      • FOIA Logs and Reports
      • FOIA Library
      • Additional FOIA Links
      • FOIA Exemptions
      • What Are Exclusions?
      • Privacy Act
      • Privacy Act Exemptions
      • Privacy Impact Assessment and Management Information Systems
    • Publications
    • Media Galleries
    • Victim Witness Assistance Program
      • Victim Witness Assistance Program Resources
      • Human Trafficking Prevention

United States Drug Enforcement Administration

  • Get Updates
  • Scam Alert
  • Full Menu
  • English
  • Español

Main Menu

Explore DEA
  • Who We Are
    • About
    • Mission
    • Leadership
    • History
    • Divisions
    • DEA Museum
    • Wall of Honor
    • Contact Us
  • What We Do
    • Forensic Sciences
    • Law Enforcement
    • Education and Prevention
    • Drug Information
    • News
    • Campaigns
  • Careers
    • Special Agent
    • Diversion Investigator
    • Intelligence Research Specialist
    • Forensic Sciences Careers
    • Professional & Administrative Careers
    • Student & Entry Level Careers
    • Employment Eligibility
    • How to Apply
  • Resources
    • Cartels
    • Illegal Online Pharmacies
    • OD Justice
    • Fentanyl Supply Chain
    • Pill Press Resources
    • Recovery Resources
    • Together for Families
    • Data and Statistics
    • FOIA
    • Publications
    • Media Galleries
    • Victim Witness Assistance Program
  • Submit A Tip

Press Releases

Advanced Search

Enter Keywords Below

Filter Results

Select To Narrow Search Results

Year

  • 2025 (4)
  • 2024 (12)
  • 2023 (21)
  • 2022 (24)
  • 2021 (56)
  • 2020 (11)
  • 2019 (4)

Subject

  • Prescription Drugs (62)
  • Pharmaceuticals/Pharmacists/Physicians (46)
  • Drug Trafficking (44)
  • Diversion Division (43)
  • Synthetic drugs (37)
  • Seizures (Drugs/Property) (30)
  • Task Forces/Task Force Officers (27)
  • Major Law Enforcement Operation (17)
  • Outreach/Drug Prevention (17)
  • Overdose (17)
  • Arrests/Convictions - Major (14)
  • OCDETF/Task Force (13)
  • Fake Pills (12)
  • Guilty Plea (9)
  • One Pill Can Kill (7)
  • Prevention/Education - DEA websites GSAD, JTT etc (7)
  • Guns/Weapons (6)
  • Press Conferences (6)
  • Fentanyl Awareness (5)
  • Take Back Day (4)
  • Public and Media Affairs - also see Congressional Affairs (3)
  • Dark Web- Internet Trafficking (2)
  • Gangs (2)
  • Intelligence Division - Intelligence Products (1)
  • Museum and Visitors Center (1)
  • Narcoterrorism (1)

Drug Name

  • Fentanyl (2491)
  • Methamphetamine (2060)
  • Cocaine (1860)
  • Heroin (1164)
  • Marijuana (Cannabis) (335)
  • Oxycodone (276)
  • Synthetic Opioids (146)
  • Ecstasy/MDMA (49)
  • Hydromorphone (37)
  • Morphine (20)
  • Amphetamines (18)
  • Steroids (18)
  • Ketamine (14)
  • Marijuana Concentrates (14)
  • Methadone (13)
  • Xylazine (12)
  • K2/Spice (11)
  • LSD (10)
  • Psilocybin (5)
  • Synthetic Bath Salts or Designer Cathinones (4)
  • GHB (2)
  • Barbiturates (1)
  • Peyote & Mescaline (1)
  • Opioids (119)
  • Benzodiazepines (23)

Field Division

  • Washington, DC (56)
  • Miami (11)
  • Seattle (10)
  • Atlanta (9)
  • New England (6)
  • San Francisco (6)
  • Dallas (5)
  • Headquarters (5)
  • St. Louis (5)
  • Chicago (4)
  • Houston (4)
  • New York (4)
  • New Jersey (2)
  • Rocky Mountain (2)
  • Detroit (1)
  • Los Angeles (1)
  • San Diego (1)
Clear All Results
PRESS RELEASE

Sovah Health to Pay United States $4.36 Million to Settle Claims of Controlled Substance Act Violations

June 08, 2022
ABINGDON, Va. – Sovah Health has agreed to pay the United States $4.36 million to settle claims that the hospital system violated the Controlled Substances Act (CSA) on numerous occasions between 2017 and 2020. As part of the resolution, Sovah Health further agreed to be subject to a period of...
June 08, 2022
PRESS RELEASE

Consent Decree Approved Between the United States and Baltimore-Based Pharmacy and Pharmacist Alleged to Have Illegally Dispensed Controlled Substances

May 12, 2022
Baltimore, Md. - U.S. District Judge Richard D. Bennett approved the United States’ consent decree with Ketan K. Dankhara, a Baltimore-based pharmacist, and Falls RX, LLC d/b/a Ultra Care Pharmacy Baltimore (“Ultra Care”), resolving the United States’ civil allegations that Dankhara and Ultra Care violated the Controlled Substances Act (“CSA”)...
May 12, 2022
PRESS RELEASE

DEA Launches First Year of Operation Engage in Richmond, VA

May 06, 2022
Richmond, Va., – Today, the Drug Enforcement Administration's (DEA) Washington Division announces the launch of Operation Engage in Richmond, Virginia. Operation Engage is comprehensive, community-level initiative, implemented to target and address the drug and related violence issues in cities with high levels of drug related problems. Operation Engage is new...
May 06, 2022
PRESS RELEASE

La DEA Inicia el Primer Año de la Operación Engage en Richmond, VA

May 06, 2022
Richmond, Virginia – Hoy, la División de Washington de la Administración para el Control de Drogas (DEA, por sus siglas en inglés) anunció el inicio de la Operación Engage en Richmond, Virginia. La cual es una iniciativa integral a nivel comunitario implementada para combatir y abordar los problemas asociados a...
May 06, 2022
PRESS RELEASE

Two Naturopaths Agree to Pay $32,000 in Civil Penalties For Improper Prescription of Opioids and Controlled Substances

April 25, 2022
SPOKANE, Wash.– Dr. Jacqueline Thomas, N.D., an East Wenatchee-based naturopathic doctor, and Dr. Rebecka Hoppins, an Edmonds-based naturopathic doctor, have each agreed to pay $16,500 to resolve allegations under the Controlled Substances Act that they improperly prescribed controlled substances. The Controlled Substances Act regulates certain drugs deemed to pose a...
April 25, 2022
PRESS RELEASE

Upper Marlboro Man Sentenced to Eight Years in Federal Prison for Heroin and Cocaine Distribution Conspiracy

April 20, 2022
Greenbelt, Maryland – U.S. District Judge Paula Xinis sentenced Charles Benjamin Stewart, Jr., age 49, of Upper Marlboro, Maryland, on April 18, 2022, to eight years in federal prison, followed by five years of supervised release for conspiracy to distribute heroin and cocaine; for illegally transporting a firearm obtained out...
April 20, 2022
PRESS RELEASE

Arlington Doctor Sentenced to 12 Years in Pill Mill Case

March 25, 2022
DALLAS, TX- An Arlington physician has been sentenced to 12 years in federal prison for fraud and drug crimes, announced DEA Special Agent in Charge Eduardo A. Chávez. In July 2021, a federal jury convicted physician Clinton Battle, 69, of one count of conspiracy to distribute controlled substances and one...
March 25, 2022
PRESS RELEASE

DEA Serves Immediate Suspension Order on Northgate Pharmacy in Waldorf, Maryland

January 27, 2022
Washington, D.C., - Jarod Forget, Special Agent in Charge of the DEA Washington Division, announced the issuance of an Immediate Suspension Order (ISO) at Northgate Pharmacy, located at 3973 Saint Charles Parkway, Waldorf, Maryland, today. This morning, members of the Drug Enforcement Administration (DEA) Washington Division’s Tactical Diversion Squad, along...
January 27, 2022
PRESS RELEASE

Former Virginia Veterinarian Pleads Guilty to Drug Charges

January 24, 2022
LYNCHBURG, Va. – A Madison Heights, Virginia man and former veterinarian pleaded guilty to a pair of misdemeanor drug charges related to his diversion of hydromorphone, an opioid drug also known under the trade name of “Dilaudid.” Patrick Gries, 54, pleaded guilty last week to one count of adulteration of...
January 24, 2022
PRESS RELEASE

Former Virginia Veterinarian Pleads Guilty to Drug Charges

January 24, 2022
LYNCHBURG, Va. – A Madison Heights, Virginia man, and former veterinarian, pleaded guilty to a pair of drug charges related to his diversion of hydromorphone, an opioid drug also known under the trade name of “Dilaudid.” Patrick Gries, 54, pleaded guilty last week to the adulteration of a drug held...
January 24, 2022
Showing 51 - 60 of 132 results

Pagination

  • First page «
  • Previous page ‹
  • Page 2
  • Page 3
  • Page 4
  • Page 5
  • Current page 6
  • Page 7
  • Page 8
  • Page 9
  • Page 10
  • Next page ›
  • Last page »
  • Who We Are
    • About
    • Domestic Divisions
    • Foreign Offices
    • Contact Us
    • DEA Museum
  • What We Do
    • Forensic Sciences
    • Law Enforcement
    • Drug Prevention
    • Diversion Control Division
    • News
  • Careers
    • Special Agent
    • Diversion Investigator
    • Forensic Sciences
    • Intelligence Research Specialist
    • How to Apply
  • Resources
    • Drug Information
    • Employee Assistance Program
    • FOIA
    • Publications
    • Media Galleries
    • VWAP
  • Doing Business
    with the DEA
    • Overview
    • Current Vendors
    • Prospective Vendors
    • Security Clauses
    • Security Forms
    • Small Business Program
    • Vendor Engagement Request
  • Policies
    • Accessibility & Policy
    • Legal Policies & Disclaimers
    • No FEAR Act
    • Privacy Policy
    • U.S. Department of Justice EEO Policy
    • USA.gov
    • Whistleblower Protection
    • Your Rights as a Federal Employee

United States Drug Enforcement Administration

DEA.gov is an official site of the U.S. Department of Justice
Facebook X LinkedIn Instagram

DEA Contact Center

(202) 307-1000 info@dea.gov
Contact the Webmaster